BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 16, 2019
View Archived Issues
Gorilla virus makes stealth vaccine vector
Read More
Results from first clinical study evaluating KB-195 in patients with urea cycle disorders
Read More
Akouos reveals lead program for sensorineural hearing loss
Read More
Armata developing AP-PA02 targeting P. aeruginosa to treat respiratory infections
Read More
A silica cage ensures thermal stability of tuberculosis vaccine candidates without refrigeration
Read More
Eisai and Biogen decide to discontinue phase III MISSION AD program of elenbecestat
Read More
Recruitment ongoing in phase I study of DFP-14927
Read More
Replimune and Regeneron initiate phase II study of cemiplimab in cutaneous squamous cell carcinoma
Read More
Mutations in the PTCD3 gene identified as a novel cause of Leigh syndrome
Read More
Design of novel zebrafish models of cystinosis
Read More
Siponimod shows efficacy in combined toxic and inflammatory animal model of multiple sclerosis
Read More
NTP-42 alone and combined with sildenafil alleviates experimental pulmonary arterial hypertension
Read More
New biomarkers for NSCLC identified
Read More
Interrupting obesity-associated breast cancer progression
Read More
Incyte divulges new MAP4K1 inhibitors
Read More
New genes linked to mitral valve prolapse
Read More
Ono Pharmaceutical patents lysophospholipid S1P5 receptor agonists
Read More
ChemoCentryx synthesizes new PD-1/PD-L1 interaction inhibitors
Read More
Universita di Pisa identifies SIRT1 activators
Read More
FDA clears initiation of phase I trial of oral foralumab
Read More
Southern Research Institute discovers NF-kappaB activators
Read More
FDA and EMA offer Auris Medical guidance on phase II/III trial with Keyzilen
Read More
Phase III CANDOR study of daratumumab in multiple myeloma meets primary endpoint
Read More
Oncotartis conducts first-in-human study of OT-82 in relapsed or refractory lymphoma
Read More
Bayer launches first-in-human study of BAY-2416964 in advanced cancer
Read More
Model of sleep-disordered breathing may clarify associated disorders
Read More